JP2011527330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527330A5 JP2011527330A5 JP2011517242A JP2011517242A JP2011527330A5 JP 2011527330 A5 JP2011527330 A5 JP 2011527330A5 JP 2011517242 A JP2011517242 A JP 2011517242A JP 2011517242 A JP2011517242 A JP 2011517242A JP 2011527330 A5 JP2011527330 A5 JP 2011527330A5
- Authority
- JP
- Japan
- Prior art keywords
- malic acid
- sunitinib
- iii
- mixture
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 45
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 38
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 38
- 235000011090 malic acid Nutrition 0.000 claims 38
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 33
- 229940099690 malic acid Drugs 0.000 claims 30
- 239000001630 malic acid Substances 0.000 claims 30
- 239000002904 solvent Substances 0.000 claims 27
- 239000002147 L01XE04 - Sunitinib Substances 0.000 claims 25
- 229960001796 sunitinib Drugs 0.000 claims 25
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 claims 25
- 239000000203 mixture Substances 0.000 claims 22
- 239000007787 solid Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 16
- LBWFXVZLPYTWQI-IPOVEDGCSA-N n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;(2s)-2-hydroxybutanedioic acid Chemical group OC(=O)[C@@H](O)CC(O)=O.CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C LBWFXVZLPYTWQI-IPOVEDGCSA-N 0.000 claims 15
- 239000002002 slurry Substances 0.000 claims 12
- 238000003756 stirring Methods 0.000 claims 11
- 238000002955 isolation Methods 0.000 claims 7
- 238000001035 drying Methods 0.000 claims 6
- 238000010992 reflux Methods 0.000 claims 5
- BJEPYKJPYRNKOW-UWTATZPHSA-N (R)-malic acid Chemical compound OC(=O)[C@H](O)CC(O)=O BJEPYKJPYRNKOW-UWTATZPHSA-N 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 238000010438 heat treatment Methods 0.000 claims 4
- 229940116298 l- malic acid Drugs 0.000 claims 4
- 230000001394 metastastic effect Effects 0.000 claims 4
- 206010061289 metastatic neoplasm Diseases 0.000 claims 4
- 238000001914 filtration Methods 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims 2
- 230000003211 malignant effect Effects 0.000 claims 2
- 208000011645 metastatic carcinoma Diseases 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229960002812 sunitinib malate Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1193/KOL/2008 | 2008-07-10 | ||
| IN1193KO2008 | 2008-07-10 | ||
| PCT/GB2009/050818 WO2010004339A1 (en) | 2008-07-10 | 2009-07-09 | Processes for the preparation of crystalline forms of sunitinib malate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527330A JP2011527330A (ja) | 2011-10-27 |
| JP2011527330A5 true JP2011527330A5 (https=) | 2012-08-23 |
Family
ID=41100787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517242A Pending JP2011527330A (ja) | 2008-07-10 | 2009-07-09 | スニチニブリンゴ酸塩の結晶形の調製方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110257237A1 (https=) |
| EP (1) | EP2297138A1 (https=) |
| JP (1) | JP2011527330A (https=) |
| CN (1) | CN102203085A (https=) |
| AU (1) | AU2009269768A1 (https=) |
| CA (1) | CA2730079A1 (https=) |
| WO (1) | WO2010004339A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102197035A (zh) * | 2008-08-25 | 2011-09-21 | 基因里克斯(英国)有限公司 | 舒尼替尼的结晶形式及其制备方法 |
| EP2499133A2 (en) * | 2009-11-12 | 2012-09-19 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline form i of l-malic acid salt of sunitinib |
| WO2011092664A1 (en) | 2010-01-29 | 2011-08-04 | Ranbaxy Laboratories Limited | Crystalline forms of l-malic acid salt of sunitinib |
| ES2709110T3 (es) * | 2012-03-23 | 2019-04-15 | Laurus Labs Ltd | Un proceso mejorado para la preparación de sunitinib y sus sales de adición de ácido |
| CA2838587A1 (en) * | 2013-10-18 | 2015-04-18 | Hari Babu Matta | Pure crystalline form ii of l-malic acid salt of sunitinib and processes for its preparation |
| CN104693187A (zh) * | 2013-12-10 | 2015-06-10 | 安杰世纪生物科技（北京）有限公司 | 一种舒尼替尼L-苹果酸盐晶型λ及其制备方法 |
| CN105085490A (zh) * | 2014-05-09 | 2015-11-25 | 上海科胜药物研发有限公司 | 新的舒尼替尼苹果酸盐晶型及其制备方法 |
| CN115057814A (zh) * | 2021-12-07 | 2022-09-16 | 山东新时代药业有限公司 | 一种米力农苹果酸盐晶体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1255752T1 (sl) * | 2000-02-15 | 2007-12-31 | Pharmacia & Upjohn Co Llc | S pirolom substituirani zaviralci 2-indolinon protein kinaza |
| GEP20063777B (en) | 2001-08-15 | 2006-03-27 | Upjohn Co | Crystals Including Malic Acid Salt of N-[2-(Diethylamino) Ethyl]-5-[(5-Fluoro-2-Oxo-3h-Indole-3-Ylidene) Methyl]-2, 4-Dimethyl-1h-Pyrrole-3-Carboxamide, Processes for Its Preparation and Compositions Thereof |
| CN1758914A (zh) * | 2003-02-24 | 2006-04-12 | 苏根公司 | 用吲哚啉酮化合物治疗过度骨质溶解 |
| US20040209937A1 (en) * | 2003-02-24 | 2004-10-21 | Sugen, Inc. | Treatment of excessive osteolysis with indolinone compounds |
| EP2220071A2 (en) * | 2007-11-21 | 2010-08-25 | Teva Pharmaceutical Industries Ltd. | Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
-
2009
- 2009-07-09 CN CN2009801339602A patent/CN102203085A/zh active Pending
- 2009-07-09 EP EP09785297A patent/EP2297138A1/en not_active Withdrawn
- 2009-07-09 WO PCT/GB2009/050818 patent/WO2010004339A1/en not_active Ceased
- 2009-07-09 CA CA2730079A patent/CA2730079A1/en not_active Abandoned
- 2009-07-09 AU AU2009269768A patent/AU2009269768A1/en not_active Abandoned
- 2009-07-09 JP JP2011517242A patent/JP2011527330A/ja active Pending
- 2009-07-09 US US13/002,917 patent/US20110257237A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011527330A5 (https=) | ||
| JP2017505329A5 (https=) | ||
| JP2018520178A5 (https=) | ||
| CN104311536A (zh) | 一种制备来那度胺的方法 | |
| CN102827153A (zh) | 阿齐沙坦的晶型及其制备方法 | |
| CN101768150A (zh) | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法 | |
| CN103360326B (zh) | 吉非替尼晶型i的精制方法 | |
| CN106866767A (zh) | 一种醋酸甲地孕酮的制备方法 | |
| CN104140414B (zh) | 阿昔替尼晶型的制备方法 | |
| CN106316986A (zh) | 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪氢溴酸盐α型晶体的制备方法 | |
| CN104387366A (zh) | 泊马度胺制备方法 | |
| CN104387421A (zh) | 阿德福韦酯一水合物及其制备方法 | |
| CN109134571B (zh) | 一种17-碘-雄甾-5,16-二烯-3β-醇的制备方法 | |
| CN105315258A (zh) | 富马酸沃诺拉赞多晶型及其制备方法 | |
| CN103910685A (zh) | 一种提纯周效磺胺的方法 | |
| CN104402920B (zh) | 一种合成2‑卤代‑3‑频那醇硼酸酯‑5‑氯苯胺的方法 | |
| CN106749060B (zh) | 一种帕托珠利的精制方法 | |
| CN103694288B (zh) | 制备2,3,4,6-四-氧-苄基-d-吡喃半乳糖的方法 | |
| CN102838649A (zh) | 一种醋酸阿比特龙的制备方法 | |
| CN104693177A (zh) | 一种埃索美拉唑钠的精制方法 | |
| CN104529864A (zh) | 一种醋酸巴多昔芬晶型a的制备方法 | |
| WO2015151190A1 (ja) | イルソグラジンマレイン酸塩の製造方法 | |
| CN103058996B (zh) | 一种氮杂环类化合物的制备方法及其用途 | |
| CN104402825A (zh) | 一种组胺二盐酸盐的合成方法 | |
| CN106380452A (zh) | 一种奥芬达唑生产过程中大幅减少溶剂使用量的方法 |